Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 1999;75:554-556; doi:10.1136/pgmj.75.887.554
© 1999 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.
Postgrad Med J 1999;75:554-556 ( September )

Short report

Digoxin, hypercalcaemia, and cardiac conduction Adrian Vellaa, Thomas C Gerberb, David L Hayesb, Guy S Reederb

a Department of Internal Medicine, Mayo Clinic & Foundation, 200 First Street SW, Rochester, MN 55905, USA Division of Endocrinology, b Division of Cardiology

Accepted 17 March 1999

The cardiac effects of hypercalcaemia are usually manifest as a shortening of the QT-interval. Hypercalcaemia is infrequently associated with a clinically manifest arrhythmia. However, concomitant therapy with digoxin or underlying cardiac disease can potentiate the arrhythmogenic effects of hypercalcaemia, leading to a symptomatic rhythm disorder. We describe a symptomatic arrhythmia, which developed in a patient with hypercalcaemia secondary to squamous cell carcinoma of the bronchus. The patient was on digoxin therapy at the time. The arrhythmia did not recur after discontinuation of digoxin therapy and correction of the hypercalcaemia. Because of its effect on cardiac conduction, hypercalcaemia should be considered in the evaluation of any patient with an unexplained bradyarrhythmia. Conversely, patients with hypercalcaemia should discontinue digoxin therapy and be evaluated for the presence of rhythm disorders while receiving appropriate treatment for hypercalcaemia.


Keywords: hypercalcaemia; bradycardia; cardiac conduction; arrhythmia


© 1999 by The Fellowship of Postgraduate Medicine

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Goyal, S. B., Spodick, D., Ritter, M. M., Newman, L. S., Feinberg, M. W., LeWine, H. E. (2005). A Bitter Tale. NEJM 352: 97-98 [Full Text]  
  • Shah, A. P., Lopez, A., Wachsner, R. Y., Meymandi, S. K., El-Bialy, A. K., Ichiuji, A. M. (2004). Sinus Node Dysfunction Secondary to Hyperparathyroidism. J CARDIOVASC PHARMACOL THER 9: 145-147 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.